Pervasive promoter hypermethylation of silenced TERT alleles in human cancers

David Esopi(AstraZeneca (United States)), Srinivasan Yegnasubramanian(Johns Hopkins University)

Cellular Oncology

May 28, 2020

10.1007/s13402-020-00531-7

Cited by 25

Related Papers

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

|Cell Reports|2021|135

A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target

|Journal of Clinical Investigation|2020|133

Distinct myeloid-derived suppressor cell populations in human glioblastoma

|Science|2025|86

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner

|PLoS ONE|2018|71

A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs

|Oncotarget|2019|18